Products & Services · Probability of success factor
HLD-0915 — Probability of success factor
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ4 2025
Last reportedQ4 2025Feb 11, 2026
How to read this metric
An increase in the probability of success suggests positive clinical data or regulatory progress, enhancing the asset's expected value. A decrease signals potential development hurdles, clinical failures, or regulatory setbacks.
Detailed definition
The estimated likelihood that the HLD-0915 product candidate will successfully navigate clinical trials, regulatory appr...
Peer comparison
Standard industry practice for valuing biotech and pharmaceutical pipelines, often benchmarked against historical success rates for similar therapeutic classes.
Metric ID:
jnj_segment_hld_0915_probability_of_success_factorHistorical Data
1 periods
| Q4 '25 | |
|---|---|
| Value | $0.68 |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's hld-0915 — probability of success factor?
- Johnson & Johnson (JNJ) reported hld-0915 — probability of success factor of $0.68 in Q4 2025.
- What does hld-0915 — probability of success factor mean?
- The statistical probability that the HLD-0915 product will successfully reach the market.